or Try an Advanced Search...

    Glucose Meter Stocks List

    Symbol Grade Name % Change
    TNDM B Tandem Diabetes Care, Inc. 0.70
    SNY B Sanofi 1.21
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Glucose Insulin Animal Health Cac 40 Cancer Caregiver Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Diabetes Diabetes Care Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dialysis Endocrine System Endocrinology

    Related ETFs - A few ETFs which own one or more of the above listed Glucose Meter stocks.

    Symbol Grade Name Weight
    EDOC D Global X Telemedicine & Digital Health ETF 6.08
    PPH C Market Vectors Pharmaceutical ETF 4.81
    VIRS C Pacer BioThreat Strategy ETF 4.26
    PID A PowerShares Intl Dividend Achievers 3.01
    MEDI D Harbor Health Care ETF 2.83
    View all Glucose Meter ETFs...
    Compare ETFs
    Compare EDOC to PID Compare PPH to PID Compare VIRS to PID

        Glucose Meter Stocks Recent News

        Date Stock Title
        May 10 SNY Fed rates, Tesla Supercharger backpedal, Novavax's 'new chapter': Market Domination
        May 10 SNY Sanofi vaccine deal kicks off Novavax's 'new chapter': Analyst
        May 10 SNY Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
        May 10 SNY Novavax stock doubles after Sanofi deal marks 'new chapter' for company
        May 10 SNY Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
        May 10 SNY Why Novavax Stock More Than Doubled Today
        May 10 SNY Top Midday Stories: Biden to Reportedly Quadruple Chinese EV Tariffs; Novavax Shares Soar on Sanofi Deal News; Protesters Try to Break Into Tesla's Plant in Germany; FDA Pushes Back Approval of Moderna Vaccine
        May 10 SNY Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
        May 10 SNY Novavax-Sanofi vaccine deal, Yelp and Sweetgreen earnings: Morning Brief
        May 10 SNY Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi
        May 10 SNY Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
        May 10 SNY Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
        May 10 SNY Update: Novavax Unveils COVID-19 Vaccine Licensing Deal With Sanofi; Shares Soar
        May 10 SNY Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern
        May 10 SNY Novavax shares skyrocket on $1.2 billion Sanofi vaccine deal
        May 10 SNY Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
        May 10 SNY These Stocks Are Moving the Most Today
        May 10 SNY Stock markets, China tariffs, Novavax and Sanofi: 3 Things
        May 10 SNY US STOCKS-Futures rise ahead of data, speeches from Fed officials
        May 10 SNY Novavax surges as Sanofi COVID vaccine deal boosts outlook
        Related Industries: Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Glucose Insulin Animal Health Cac 40 Cancer Caregiver Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Diabetes Diabetes Care Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dialysis Endocrine System Endocrinology
        Glucose Meter

        A glucose meter is a medical device for measuring the amount of glucose in the blood. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking the skin with a lancet, is placed on a disposable test strip that the meter reads and uses to calculate the blood glucose level. The meter then displays the level in mg/dl or mmol/l.

        Browse All Tags